Exacerbation of Pre-Existing Chronic Pain in Older Adults After SARS-CoV-2 Infection: A Single-Center, Cross-Sectional, Observational Study

References

• Bakılan F, Gökmen OG, Ortanca B, et al. Musculoskeletal symptoms and related factors in postacute COVID-19 patients. Int J Clin Pract. 2021;75(11):e14734. doi:10.1111/ijcp.14734
   PubMed Web of Science ®Google Scholar
• Kubota GT, Soares F, Da FA, et al. Pain paths among post-COVID-19 condition subjects: a prospective cross-sectional study with in-person evaluation. Eur J Pain. 2023;27(5):636–650. doi:10.1002/ejp.2094
   PubMed Web of Science ®Google Scholar
• Clauw DJ, Häuser W, Cohen SP, Fitzcharles MA. Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain. 2020;161(8):1694–1697. doi:10.1097/j.pain.0000000000001950
   PubMed Web of Science ®Google Scholar
• Fernández-de-Las-Peñas C, Ryan-Murua P, De-la-Llave-Rincón AI, Gómez-Mayordomo V, Arendt-Nielsen L, Torres-Macho J. Serological biomarkers of COVID-19 severity at hospital admission are not related to long-term post-COVID pain symptoms in hospitalized COVID-19 survivors. Pain. 2022;163(11):2112–2117. doi:10.1097/j.pain.0000000000002608
   PubMed Web of Science ®Google Scholar
• Fernández-de-Las-Peñas C, Navarro-Santana M, Plaza-Manzano G, Palacios-Ceña D, Arendt-Nielsen L. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis. Pain. 2022;163(7):1220–1231. doi:10.1097/j.pain.0000000000002496
   PubMed Web of Science ®Google Scholar
• Fernández-de-Las-Peñas C, De-la-Llave-Rincón AI, Ortega-Santiago R, et al. Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: a multicenter study. Pain. 2022;163(9):e989–e996. doi:10.1097/j.pain.0000000000002564
   PubMed Web of Science ®Google Scholar
• Fernández-de-Las-Peñas C, Cancela-Cilleruelo I, Moro-López-Menchero P, et al. Prevalence of Musculoskeletal Post-COVID Pain in Hospitalized COVID-19 Survivors Depending on Infection with the Historical, Alpha or Delta SARS-CoV-2 Variant. Biomedicines. 2022;10(8):1951. doi:10.3390/biomedicines10081951
   PubMed Web of Science ®Google Scholar
• Kumar A, Prasoon P, Kumari C, et al. SARS-CoV-2-specific virulence factors in COVID-19. J Med Virol. 2021;93(3):1343–1350. doi:10.1002/jmv.26615
   PubMed Web of Science ®Google Scholar
• Fuentes E, Fuentes M, Alarcón M, Palomo I. Immune System Dysfunction in the Elderly. An Acad Bras Cienc. 2017;89(1):285–299. doi:10.1590/0001-3765201720160487
   PubMed Web of Science ®Google Scholar
• Treede RD, Rief W, Barke A, et al. A classification of chronic pain for ICD-11. Pain. 2015;156(6):1003–1007. doi:10.1097/j.pain.0000000000000160
   PubMed Web of Science ®Google Scholar
• Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1–2):29–36. doi:10.1016/j.pain.2004.12.010
   PubMed Web of Science ®Google Scholar
• Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736. doi:10.1007/s11136-011-9903-x
   PubMed Web of Science ®Google Scholar
• Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L Value Set for China. Value Health. 2017;20(4):662–669. doi:10.1016/j.jval.2016.11.016
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep. 2006;29(9):1155–1173. doi:10.1093/sleep/29.9.1155
   PubMed Web of Science ®Google Scholar
• Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic meta-analysis. Gen Hosp Psychiatry. 2016;39:24–31. doi:10.1016/j.genhosppsych.2015.11.005
   PubMed Web of Science ®Google Scholar
• Levis B, Benedetti A, Thombs BD. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365:l1476. doi:10.1136/bmj.l1476
   PubMed Web of Science ®Google Scholar
• Thompson EJ, Williams DM, Walker AJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528. doi:10.1038/s41467-022-30836-0
   PubMed Web of Science ®Google Scholar
• Fernández-de-Las-Peñas C, Notarte KI, Peligro PJ, et al. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: a Systematic Review of the Literature. Viruses. 2022;14(12):2629. doi:10.3390/v14122629
   PubMed Web of Science ®Google Scholar
• Wang F, Nie J, Wang H, et al. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis. 2020;221(11):1762–1769. doi:10.1093/infdis/jiaa150
   PubMed Web of Science ®Google Scholar
• Mucha SR, Dugar S, McCrae K, et al. Coagulopathy in COVID-19: manifestations and management. Cleve Clin J Med. 2020;87(8):461–468. doi:10.3949/ccjm.87a.ccc024
   PubMed Web of Science ®Google Scholar
• Eljilany I, Elzouki AN. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: a Narrative Review. Vasc Health Risk Manag. 2020;16:455–462. doi:10.2147/VHRM.S280962
   PubMed Web of Science ®Google Scholar
• Karaarslan F, Güneri FD, Kardeş S. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol. 2022;41(1):289–296. doi:10.1007/s10067-021-05942-x
   PubMed Web of Science ®Google Scholar
• Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3–20. doi:10.1038/s41580-021-00418-x
   PubMed Web of Science ®Google Scholar
• Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell. 2020;183(1):16–27. doi:10.1016/j.cell.2020.08.028
   PubMed Web of Science ®Google Scholar
• Drosos AA, Pelechas E, Voulgari PV. Long COVID from rheumatology perspective: a simple mimicker or promoter of autoimmunity? Clin Rheumatol. 2022;41(3):957–958. doi:10.1007/s10067-022-06092-4
   PubMed Web of Science ®Google Scholar
• Gaebler C, Wang Z, Lorenzi J, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639–644. doi:10.1038/s41586-021-03207-w
   PubMed Web of Science ®Google Scholar
• Joshi D, Gyanpuri V, Pathak A, et al. Neuropathic Pain Associated with COVID-19: a Systematic Review of Case Reports. Curr Pain Headache Rep. 2022;26(8):595–603. doi:10.1007/s11916-022-01065-3
   PubMed Web of Science ®Google Scholar
• Straburzyński M, Kuca-Warnawin E, Waliszewska-Prosół M. COVID-19-related headache and innate immune response - A narrative review. Neurol Neurochir Pol. 2023;57(1):43–52. doi:10.5603/PJNNS.a2022.0049
   PubMed Web of Science ®Google Scholar
• Waliszewska-Prosół M, Budrewicz S. The unusual course of a migraine attack during COVID-19 infection - Case studies of three patients. J Infect Public Health. 2021;14(7):903–905. doi:10.1016/j.jiph.2021.04.013
   PubMed Web of Science ®Google Scholar
• Castaldo M, Waliszewska-Prosół M, Koutsokera M, et al. Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis. J Headache Pain. 2022;23(1):41. doi:10.1186/s10194-022-01400-4
   PubMed Web of Science ®Google Scholar
• Straburzyński M, Nowaczewska M, Budrewicz S, Waliszewska-Prosół M. COVID-19-related headache and sinonasal inflammation: a longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection. Cephalalgia. 2022;42(3):218–228. doi:10.1177/03331024211040753
   PubMed Web of Science ®Google Scholar